Published in Emerg Infect Dis on January 01, 2010
Novel hepatitis E virus genotype in Norway rats, Germany. Emerg Infect Dis (2010) 2.01
A systematic review of the epidemiology of hepatitis E virus in Africa. BMC Infect Dis (2014) 1.55
Estimating the burden of maternal and neonatal deaths associated with jaundice in Bangladesh: possible role of hepatitis E infection. Am J Public Health (2012) 1.08
Hepatitis E: Epidemiology and prevention. World J Hepatol (2011) 1.01
Novel risk factors associated with hepatitis E virus infection in a large outbreak in northern Uganda: results from a case-control study and environmental analysis. Am J Trop Med Hyg (2010) 0.98
Hepatitis e: epidemiology and natural history. J Clin Exp Hepatol (2013) 0.88
Hepatitis E vaccine debuts. Nature (2012) 0.88
Epidemiology of zoonotic hepatitis E: a community-based surveillance study in a rural population in China. PLoS One (2014) 0.87
Outbreak of hepatitis E in urban Bangladesh resulting in maternal and perinatal mortality. Clin Infect Dis (2014) 0.84
Transmission of Hepatitis E Virus in Developing Countries. Viruses (2016) 0.83
Acute risk for hepatitis E virus infection among HIV-1-positive pregnant women in central Africa. Virol J (2012) 0.83
Population Movement and Virus Spreading: HEV Spreading in a Pilgrimage City, Mashhad in Northeast Iran; an Example. Hepat Mon (2013) 0.82
Identification of Distribution Characteristics and Epidemic Trends of Hepatitis E in Zhejiang Province, China from 2007 to 2012. Sci Rep (2016) 0.77
The WASH approach: fighting waterborne diseases in emergency situations. Environ Health Perspect (2015) 0.75
Serologic evidence for hepatitis E virus infection among patients with undifferentiated acute febrile illness in Kibera, Kenya. J Clin Virol (2016) 0.75
A Case Report About the Most Common Yet Most Forgotten Hepatitis E. Am J Case Rep (2016) 0.75
Hepatitis E virus: Current epidemiology and vaccine. Hum Vaccin Immunother (2016) 0.75
A Single Lineage of Hepatitis E Virus Causes Both Outbreaks and Sporadic Hepatitis in Sudan. Viruses (2016) 0.75
Safety and efficacy of a recombinant hepatitis E vaccine. N Engl J Med (2007) 5.87
Study of an epidemic of non-A, non-B hepatitis. Possibility of another human hepatitis virus distinct from post-transfusion non-A, non-B type. Am J Med (1980) 3.94
A large waterborne viral hepatitis E epidemic in Kanpur, India. Bull World Health Organ (1992) 1.91
A large outbreak of hepatitis E among a displaced population in Darfur, Sudan, 2004: the role of water treatment methods. Clin Infect Dis (2006) 1.80
High mortality associated with an outbreak of hepatitis E among displaced persons in Darfur, Sudan. Clin Infect Dis (2006) 1.77
Infectivity titration of a prototype strain of hepatitis E virus in cynomolgus monkeys. J Med Virol (1994) 1.58
Genetic heterogeneity of hepatitis E virus in Darfur, Sudan, and neighboring Chad. J Med Virol (2005) 1.24
Hepatitis E. Infect Dis Clin North Am (2000) 1.19
Outbreak of acute hepatitis E virus infection among military personnel in northern Ethiopia. J Med Virol (1991) 1.06
An outbreak of enterically transmitted non-A, non-B hepatitis in Pakistan. Am J Trop Med Hyg (1989) 1.05
Acute viral hepatitis morbidity and mortality associated with hepatitis E virus infection: Uzbekistan surveillance data. BMC Infect Dis (2009) 0.89
Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N Engl J Med (2012) 27.84
Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study. J Acquir Immune Defic Syndr (2006) 12.07
Survival benefit of initiating antiretroviral therapy in HIV-infected persons in different CD4+ cell strata. Ann Intern Med (2003) 8.05
Randomized, double-blind, placebo-controlled efficacy trial of a bivalent recombinant glycoprotein 120 HIV-1 vaccine among injection drug users in Bangkok, Thailand. J Infect Dis (2006) 7.98
Incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992-2003. Ann Intern Med (2008) 7.71
The increasing burden of mortality from viral hepatitis in the United States between 1999 and 2007. Ann Intern Med (2012) 7.56
Quantitative detection of increasing HIV type 1 antibodies after seroconversion: a simple assay for detecting recent HIV infection and estimating incidence. AIDS Res Hum Retroviruses (2002) 7.03
Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945-1965. MMWR Recomm Rep (2012) 6.91
Newly discovered ebola virus associated with hemorrhagic fever outbreak in Uganda. PLoS Pathog (2008) 6.07
Recommendations for identification and public health management of persons with chronic hepatitis B virus infection. MMWR Recomm Rep (2008) 6.02
Rapid diagnosis of Ebola hemorrhagic fever by reverse transcription-PCR in an outbreak setting and assessment of patient viral load as a predictor of outcome. J Virol (2004) 5.86
Assessment of a pilot antiretroviral drug therapy programme in Uganda: patients' response, survival, and drug resistance. Lancet (2002) 5.80
A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: immunization of adults. MMWR Recomm Rep (2006) 5.63
Efficacy of a brief case management intervention to link recently diagnosed HIV-infected persons to care. AIDS (2005) 5.43
Investigation of bioterrorism-related anthrax, United States, 2001: epidemiologic findings. Emerg Infect Dis (2002) 5.23
Risk factors for recent HIV infection in Uganda. JAMA (2008) 4.84
Mortality in HIV-infected Ugandan adults receiving antiretroviral treatment and survival of their HIV-uninfected children: a prospective cohort study. Lancet (2008) 4.70
Isolation of genetically diverse Marburg viruses from Egyptian fruit bats. PLoS Pathog (2009) 4.56
Rates of virological failure in patients treated in a home-based versus a facility-based HIV-care model in Jinja, southeast Uganda: a cluster-randomised equivalence trial. Lancet (2009) 4.33
Hepatitis C virus testing of persons born during 1945-1965: recommendations from the Centers for Disease Control and Prevention. Ann Intern Med (2012) 4.29
Effect of co-trimoxazole prophylaxis on morbidity, mortality, CD4-cell count, and viral load in HIV infection in rural Uganda. Lancet (2004) 4.19
Syphilis increases HIV viral load and decreases CD4 cell counts in HIV-infected patients with new syphilis infections. AIDS (2004) 4.17
Population-based hematologic and immunologic reference values for a healthy Ugandan population. Clin Diagn Lab Immunol (2004) 3.92
The cost-effectiveness of birth-cohort screening for hepatitis C antibody in U.S. primary care settings. Ann Intern Med (2011) 3.80
Transmission of human herpesvirus 8 by blood transfusion. N Engl J Med (2006) 3.80
Asymptomatic serum cryptococcal antigenemia and early mortality during antiretroviral therapy in rural Uganda. Trop Med Int Health (2007) 3.69
Chronic hepatitis C virus infection in the United States, National Health and Nutrition Examination Survey 2003 to 2010. Ann Intern Med (2014) 3.50
Characteristics of HIV-1 serodiscordant couples enrolled in a clinical trial of antiretroviral pre-exposure prophylaxis for HIV-1 prevention. PLoS One (2011) 3.27
Mental health problems among adults in tsunami-affected areas in southern Thailand. JAMA (2006) 3.25
Cholera surveillance during the Haiti epidemic--the first 2 years. N Engl J Med (2013) 3.19
Sedentary behaviors increase risk of cardiovascular disease mortality in men. Med Sci Sports Exerc (2010) 3.06
Chronic hepatitis E in an immunocompetent patient: a case report. Hepatology (2013) 2.97
Influence of coinfection with hepatitis C virus on morbidity and mortality due to human immunodeficiency virus infection in the era of highly active antiretroviral therapy. Clin Infect Dis (2003) 2.58
Evidence of a previously undocumented epidemic of HIV infection among men who have sex with men in Bangkok, Thailand. AIDS (2005) 2.58
Is sexual contact a major mode of hepatitis C virus transmission? Hepatology (2010) 2.58
Evidence of person-to-person transmission of hepatitis E virus during a large outbreak in Northern Uganda. Clin Infect Dis (2010) 2.57
Cotrimoxazole prophylaxis by HIV-infected persons in Uganda reduces morbidity and mortality among HIV-uninfected family members. AIDS (2005) 2.50
Antiretroviral therapy improves renal function among HIV-infected Ugandans. Kidney Int (2008) 2.49
Antibacterial medication use during pregnancy and risk of birth defects: National Birth Defects Prevention Study. Arch Pediatr Adolesc Med (2009) 2.45
Isoniazid, rifampin, ethambutol, and pyrazinamide pharmacokinetics and treatment outcomes among a predominantly HIV-infected cohort of adults with tuberculosis from Botswana. Clin Infect Dis (2009) 2.36
Low CD4+ T cell count is a risk factor for cardiovascular disease events in the HIV outpatient study. Clin Infect Dis (2010) 2.34
CD4+ T-cell count monitoring does not accurately identify HIV-infected adults with virologic failure receiving antiretroviral therapy. J Acquir Immune Defic Syndr (2008) 2.32
Sequence-specific peptide synthesis by an artificial small-molecule machine. Science (2013) 2.29
Nonhospital health care-associated hepatitis B and C virus transmission: United States, 1998-2008. Ann Intern Med (2009) 2.28
Amphetamine use is associated with increased HIV incidence among men who have sex with men in San Francisco. AIDS (2005) 2.22
Detection of acute HIV infections in high-risk patients in California. J Acquir Immune Defic Syndr (2006) 2.15
Hepatitis B and C virus infection among 1.2 million persons with access to care: factors associated with testing and infection prevalence. Clin Infect Dis (2012) 2.15
Effect of home-based water chlorination and safe storage on diarrhea among persons with human immunodeficiency virus in Uganda. Am J Trop Med Hyg (2005) 2.12
Development of proteinuria or elevated serum creatinine and mortality in HIV-infected women. J Acquir Immune Defic Syndr (2003) 2.11
Hepatitis B virus transmissions associated with a portable dental clinic, West Virginia, 2009. J Am Dent Assoc (2013) 2.07
Suppressive acyclovir therapy reduces HIV cervicovaginal shedding in HIV- and HSV-2-infected women, Chiang Rai, Thailand. J Acquir Immune Defic Syndr (2008) 2.05
Antiretroviral therapy during tuberculosis treatment and marked reduction in death rate of HIV-infected patients, Thailand. Emerg Infect Dis (2007) 2.04
Evaluation of a sensitive/less sensitive testing algorithm using the bioMérieux Vironostika-LS assay for detecting recent HIV-1 subtype B' or E infection in Thailand. AIDS Res Hum Retroviruses (2003) 2.04
Outbreak of leptospirosis among triathlon participants and community residents in Springfield, Illinois, 1998. Clin Infect Dis (2002) 2.02
Depression and CD4 cell count among persons with HIV infection in Uganda. AIDS Behav (2006) 2.01
Hepatitis E virus infection may be transmitted through blood transfusions in an endemic area. J Gastroenterol Hepatol (2004) 2.01
First confirmed cases of Middle East respiratory syndrome coronavirus (MERS-CoV) infection in the United States, updated information on the epidemiology of MERS-CoV infection, and guidance for the public, clinicians, and public health authorities - May 2014. MMWR Morb Mortal Wkly Rep (2014) 2.00
Seasonal pulses of Marburg virus circulation in juvenile Rousettus aegyptiacus bats coincide with periods of increased risk of human infection. PLoS Pathog (2012) 2.00
HIV care and treatment factors associated with improved survival during TB treatment in Thailand: an observational study. BMC Infect Dis (2009) 2.00
Durability and predictors of success of highly active antiretroviral therapy for ambulatory HIV-infected patients. AIDS (2002) 1.99
Symptoms of posttraumatic stress disorder and depression among children in tsunami-affected areas in southern Thailand. JAMA (2006) 1.98
CD4 cell count and viral load monitoring in patients undergoing antiretroviral therapy in Uganda: cost effectiveness study. BMJ (2011) 1.96
Risk factors for Buruli ulcer disease (Mycobacterium ulcerans Infection): results from a case-control study in Ghana. Clin Infect Dis (2005) 1.95
Hepatitis B testing and access to care among racial and ethnic minorities in selected communities across the United States, 2009-2010. Hepatology (2013) 1.93
Modification of the incidence of drug-associated symmetrical peripheral neuropathy by host and disease factors in the HIV outpatient study cohort. Clin Infect Dis (2004) 1.91
Elimination of cholera transmission in Haiti and the Dominican Republic. Lancet (2012) 1.91
Cryptosporidiosis and microsporidiosis in ugandan children with persistent diarrhea with and without concurrent infection with the human immunodeficiency virus. Am J Trop Med Hyg (2005) 1.90
Surveillance for unexplained deaths and critical illnesses due to possibly infectious causes, United States, 1995-1998. Emerg Infect Dis (2002) 1.89
Intersubtype human immunodeficiency virus type 1 superinfection following seroconversion to primary infection in two injection drug users. J Virol (2002) 1.80
HIV infection among men who have sex with men in Kampala, Uganda--a respondent driven sampling survey. PLoS One (2012) 1.79
Baseline characteristics and mortality among people in care for chronic viral hepatitis: the chronic hepatitis cohort study. Clin Infect Dis (2012) 1.79
Influenza surveillance in 15 countries in Africa, 2006-2010. J Infect Dis (2012) 1.76
Proportion of deaths and clinical features in Bundibugyo Ebola virus infection, Uganda. Emerg Infect Dis (2010) 1.75
Palmtop-assisted self-interviewing for the collection of sensitive behavioral data: randomized trial with drug use urine testing. Am J Epidemiol (2005) 1.72
HIV-1 virologic and immunologic progression and initiation of antiretroviral therapy among HIV-1-infected subjects in a trial of the efficacy of recombinant glycoprotein 120 vaccine. J Infect Dis (2005) 1.70
Increases in hepatitis C virus infection related to injection drug use among persons aged ≤30 years - Kentucky, Tennessee, Virginia, and West Virginia, 2006-2012. MMWR Morb Mortal Wkly Rep (2015) 1.69
The two faces of hepatitis E virus. Clin Infect Dis (2010) 1.69